Thalys Medical Technology Group Balance Sheet Health
Financial Health criteria checks 2/6
Thalys Medical Technology Group has a total shareholder equity of CN¥1.3B and total debt of CN¥1.0B, which brings its debt-to-equity ratio to 79.7%. Its total assets and total liabilities are CN¥3.3B and CN¥2.0B respectively. Thalys Medical Technology Group's EBIT is CN¥4.5M making its interest coverage ratio 0.1. It has cash and short-term investments of CN¥175.4M.
Key information
79.7%
Debt to equity ratio
CN¥1.05b
Debt
Interest coverage ratio | 0.07x |
Cash | CN¥175.36m |
Equity | CN¥1.32b |
Total liabilities | CN¥1.99b |
Total assets | CN¥3.31b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 603716's short term assets (CN¥2.4B) exceed its short term liabilities (CN¥1.3B).
Long Term Liabilities: 603716's short term assets (CN¥2.4B) exceed its long term liabilities (CN¥640.0M).
Debt to Equity History and Analysis
Debt Level: 603716's net debt to equity ratio (66.4%) is considered high.
Reducing Debt: 603716's debt to equity ratio has increased from 50.5% to 79.7% over the past 5 years.
Debt Coverage: 603716's debt is not well covered by operating cash flow (5.7%).
Interest Coverage: 603716's interest payments on its debt are not well covered by EBIT (0.1x coverage).